| __timestamp | Geron Corporation | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8901000 | 5903000 |
| Thursday, January 1, 2015 | 9574000 | 2762000 |
| Friday, January 1, 2016 | 14695000 | 1114000 |
| Sunday, January 1, 2017 | 8437000 | 25573000 |
| Monday, January 1, 2018 | 12723000 | 6000000 |
| Tuesday, January 1, 2019 | 51272000 | 38845000 |
| Wednesday, January 1, 2020 | 50052000 | 50523000 |
| Friday, January 1, 2021 | 783000 | 75463000 |
| Saturday, January 1, 2022 | 868000 | 105767000 |
| Sunday, January 1, 2023 | 123740000 | 167512000 |
Infusing magic into the data realm
In the evolving landscape of biotechnology, understanding cost structures is crucial. From 2014 to 2023, Xenon Pharmaceuticals Inc. and Geron Corporation have shown distinct trajectories in their cost of revenue. Xenon Pharmaceuticals saw a staggering 2,736% increase, peaking in 2023, while Geron Corporation experienced a more modest 1,289% rise over the same period. Notably, Xenon's costs surged significantly in 2021, marking a pivotal shift. This trend underscores Xenon's aggressive expansion and investment in R&D, contrasting with Geron's more conservative fiscal approach. The data highlights the dynamic nature of the biotech sector, where strategic financial management can dictate market positioning. As these companies continue to innovate, their cost strategies will be pivotal in shaping their competitive edge.
Cost of Revenue Comparison: Merck & Co., Inc. vs Xenon Pharmaceuticals Inc.
Takeda Pharmaceutical Company Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Incyte Corporation vs Xenon Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Geron Corporation
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Jazz Pharmaceuticals plc and Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Cytokinetics, Incorporated and Xenon Pharmaceuticals Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Alkermes plc vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: Xenon Pharmaceuticals Inc. and Bausch Health Companies Inc.
Cost of Revenue Comparison: Xenon Pharmaceuticals Inc. vs Xencor, Inc.
Cost of Revenue Comparison: Geron Corporation vs Travere Therapeutics, Inc.